부산대학교 도서관

O'Donnell, Elizabeth ; Mo, Clifton ; Yee, Andrew J ; Nadeem, Omar ; Laubach, Jacob ; Rosenblatt, Jacalyn ; Munshi, Nikhil ; Midha, Shonali ; Cirstea, Diana ; Chrysafi, Pavlina ; Horick, Nora ; Richardson, Paul G ; Raje, Noopur

In The Lancet Haematology June 2024 11(6):e415-e424

Yee, Andrew J ; Bensinger, William I ; Supko, Jeffrey G ; Voorhees, Peter M ; Berdeja, Jesus G ; Richardson, Paul G ; Libby, Edward N ; Wallace, Ellen E ; Birrer, Nicole E ; Burke, Jill N ; Tamang, David L ; Yang, Min ; Jones, Simon S ; Wheeler, Catherine A ; Markelewicz, Robert J ; Raje, Noopur S

In The Lancet Oncology November 2016 17(11):1569-1578

Rodriguez C; Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Rodriguez T; Department of Hematology & Hematopoietic Cell Transplantation, City of Hope Cancer Center, Chicago, IL, USA.; Kentos A; Department of Hematology, Centre Hospitalier Jolimont, Haine-Saint-Paul, Belgium.; Driessen C; Department of Medical Oncology and Hematology, Kantonsspital St. Gallen, St. Gallen, Switzerland.; Sunami K; Department of Hematology, NHO, Okayama Medical Center, Okayama, Japan.; Lesokhin AM; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Yee AJ; Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Minella AC; Amgen, Thousand Oaks, CA, USA.; Maraboina R; IQVIA, Hyderabad, India.; Upreti VV; Amgen, South San Francisco, CA, USA.; Zhou D; Amgen, South San Francisco, CA, USA.; Shabooti M; Amgen, Thousand Oaks, CA, USA.; Stieglmaier J; Amgen Research (Munich) GmbH, Munich, Germany.; Quach H; St. Vincent's Hospital Melbourne, University of Melbourne, Melbourne, Australia.

Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE

Lei, Matthew M ; Tavares, Erica ; Lou, Uvette ; Buzgo, Evan ; Raje, Noopur S. ; Yee, Andrew J

In Blood 5 November 2020 136 Supplement 1:14-16

Datar, Yesh; Clerc, Olivier F; Cuddy, Sarah A M; Kim, Sirwoo; Taylor, Alexandra; Neri, Jocelyn Canseco; Benz, Dominik C; Bianchi, Giada; Yee, Andrew J; Sanchorawala, Vaishali; Ruberg, Frederick L; Landau, Heather; Liao, Ronglih; Kijewski, Marie Foley; Jerosch-Herold, Michael; Kwong, Raymond Y; Carli, Marcelo F Di; Falk, Rodney H; Dorbala, Sharmila

European Heart Journal - Cardiovascular Imaging; May2024, Vol. 25 Issue 5, p687-697, 11p

Gustine JN; Department of Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Scaringi JA; Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Bauer F; Institute for Diagnostic and Interventional Radiology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Cirstea DD; Department of Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Branagan AR; Department of Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Puliafito BR; Department of Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Maus MV; Department of Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Frigault MJ; Department of Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Yee AJ; Department of Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Mahmood U; Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Raje NS; Department of Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. nraje@mgh.harvard.edu.

Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE; In Process

Blumenberg V; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, Charlestown, Massachusetts, United States.; Birocchi F; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., United States.; Shih A; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., United States.; Escobar G; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, United States.; Mucci A; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, United States.; Armstrong A; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, United States.; Cirstea DD; Department of Medicine, Hematology, and Oncology Division, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA., United States.; Harris DL; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Charlestown, Massachusetts, United States.; Bozym DJ; Department of Medicine, Hematology, and Oncology Division, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA., United States.; Puliafito BR; Department of Medicine, Hematology, and Oncology Division, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA., United States.; Newcomb RA; Department of Medicine, Hematology, and Oncology Division, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA., United States.; Dhawale TM; Department of Medicine, Hematology, and Oncology Division, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA., United States.; Johnson PC; Department of Medicine, Hematology, and Oncology Division, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA., United States.; El-Jawahri A; Department of Medicine, Hematology, and Oncology Division, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA., United States.; Jeffrey R 3rd; MGH / Harvard Medical School, Charlestown, Massachusetts, United States.; Barselau A; Department of Medicine, Hematology, and Oncology Division, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA., United States.; Li A; Department of Medicine, Hematology, and Oncology Division, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA., United States.; Emmanuel-Alejandro E; Department of Medicine, Hematology, and Oncology Division, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA., United States.; Cook D; Department of Medicine, Hematology, and Oncology Division, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA., United States.; Lindell KA; Department of Medicine, Hematology, and Oncology Division, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA., United States.; Luk SO; Department of Medicine, Hematology, and Oncology Division, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA., United States.; Chaffee R; Department of Medicine, Hematology, and Oncology Division, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA., United States.; Yee AJ; Department of Medicine, Hematology, and Oncology Division, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA., United States.; Branagan AR; Department of Medicine, Hematology, and Oncology Division, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA., United States.; Raje NS; Department of Medicine, Hematology, and Oncology Division, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA., United States.; Graham C; Comprehensive Cancer Centre, King's College London, London, UK., United Kingdom.; Hammond SP; Transplant and Immunocompromised Host Infectious Diseases, Infectious Diseases Division, Massachusetts General Hospital, Boston, Massachusetts, USA., United States.; Bushman FD; Perelman School of Medicine at the University of Pennsylvania, Department of Microbiology, Philadelphia, PA, USA., United States.; Roche AM; Perelman School of Medicine at the University of Pennsylvania, Department of Microbiology, Philadelphia, PA, USA., United States.; Reddy S; Perelman School of Medicine at the University of Pennsylvania, Department of Microbiology, Philadelphia, PA, USA., United States.; McFarland AG; Perelman School of Medicine at the University of Pennsylvania, Department of Microbiology, Philadelphia, PA, USA., United States.; Chen YB; Department of Medicine, Hematology, and Oncology Division, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA., United States.; Choi BD; Division of Neurosurgery, Massachusetts General Hospital, and Harvard Medical School, Boston, MA 02114, USA., United States.; Mount CW; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., United States.; Dougan M; Division of Gastroenterology and Department of Medicine, Massachusetts General Hospital, and Harvard Medical School, Boston, MA 02114, USA., United States.; Nardi V; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., United States.; Sohani A; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., United States.; Gallagher KME; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., United States.; Maus MV; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., United States.; Frigault MJ; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., United States.; Leick MB; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., United States.

Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Ababneh HS; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Yee AJ; Division of Hematology & Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Raje NS; Division of Hematology & Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Frigault MJ; Division of Hematology & Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Johnson PC; Division of Hematology & Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Patel CG; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: cpatel@mgh.harvard.edu.

Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8407192 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0887 (Electronic) Linking ISSN: 01678140 NLM ISO Abbreviation: Radiother Oncol Subsets: MEDLINE

Cirstea D; Center for Multiple Myeloma, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Shome R; Center for Multiple Myeloma, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Samur M; Department of Data Science, Dana Farber Cancer Institute, Harvard TH Chan School of Public Health, Boston, USA.; Talluri S; Jerome Lipper Multiple Myeloma Center, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; VA Boston Healthcare System, Boston, MA, USA.; Connolly JJ; Program for the Coordination and Oversight of Research Protocols, Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Wright AJ; Program for the Coordination and Oversight of Research Protocols, Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Duvallet E; OncoPep, Inc, Cambridge, MA, USA.; Joyce ANR; OncoPep, Inc, Cambridge, MA, USA.; Lively K; Center for Multiple Myeloma, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Basinsky G; Program for the Coordination and Oversight of Research Protocols, Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Yee AJ; Center for Multiple Myeloma, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Chase CC; Duke Blood Cancer Center, Durham, NC, USA.; Malek E; Case Western Reserve University, Cleveland, OH, USA.; Niesvizky R; Division of Hematology & Medical Oncology, Weill Cornell Medicine/New York Presbyterian Hospital, Forest Hills, NY, USA.; Richardson PG; Jerome Lipper Multiple Myeloma Center, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Raje NS; Center for Multiple Myeloma, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. nraje@mgh.harvard.edu.

Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE; In Process

Derman BA; Section of Hematology/Oncology, The University of Chicago, Chicago, IL.; Yee AJ; Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA.

Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Benz DC; Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Cardiac Amyloidosis Program, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; CV Imaging Program, Cardiovascular Division and Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Clerc OF; Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Cardiac Amyloidosis Program, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; CV Imaging Program, Cardiovascular Division and Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Cuddy SAM; Cardiac Amyloidosis Program, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; CV Imaging Program, Cardiovascular Division and Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Singh V; Cardiac Amyloidosis Program, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; CV Imaging Program, Cardiovascular Division and Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Kijewski MF; Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; CV Imaging Program, Cardiovascular Division and Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Bianchi G; Cardiac Amyloidosis Program, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Yee AJ; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Ruberg FL; Section of Cardiovascular Medicine, Department of Medicine, Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA; Amyloidosis Center, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.; Jerosch-Herold M; CV Imaging Program, Cardiovascular Division and Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Kwong RY; CV Imaging Program, Cardiovascular Division and Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Di Carli MF; Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; CV Imaging Program, Cardiovascular Division and Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Liao R; Amyloidosis Program, Stanford University, Stanford, California, USA.; Falk RH; Cardiac Amyloidosis Program, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Dorbala S; Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Cardiac Amyloidosis Program, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; CV Imaging Program, Cardiovascular Division and Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Electronic address: sdorbala@bwh.harvard.edu.

Publisher: Elsevier Country of Publication: United States NLM ID: 101467978 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1876-7591 (Electronic) Linking ISSN: 18767591 NLM ISO Abbreviation: JACC Cardiovasc Imaging Subsets: MEDLINE

Frede J; Department of Medical Oncology, Jerome Lipper Multiple Myeloma Center, Dana Farber Cancer Institute, Boston, MA, USA. julia.frede@tum.de.; Harvard Medical School, Boston, MA, USA. julia.frede@tum.de.; Broad Institute of MIT and Harvard, Cambridge, MA, USA. julia.frede@tum.de.; Technical University of Munich, School of Medicine and Health, Institute of Clinical Chemistry and Pathobiochemistry, TUM University Hospital, Munich, Germany. julia.frede@tum.de.; Poller JC; Department of Medical Oncology, Jerome Lipper Multiple Myeloma Center, Dana Farber Cancer Institute, Boston, MA, USA.; TUM School of Medicine and Health, Department for Internal Medicine II, Technical University of Munich, TUM University Hospital, Munich, Germany.; Heidelberg Myeloma Center, Department of Medicine V, University Hospital and Medical Faculty, Heidelberg University, Heidelberg, Germany.; Shi K; Department of Medical Oncology, Jerome Lipper Multiple Myeloma Center, Dana Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Heidelberg Myeloma Center, Department of Medicine V, University Hospital and Medical Faculty, Heidelberg University, Heidelberg, Germany.; Stuart H; Department of Medical Oncology, Jerome Lipper Multiple Myeloma Center, Dana Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Sotudeh N; Department of Medical Oncology, Jerome Lipper Multiple Myeloma Center, Dana Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Havig C; Harvard Medical School, Boston, MA, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Lim K; Department of Medical Oncology, Jerome Lipper Multiple Myeloma Center, Dana Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Wiggers CRM; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Cho EY; Harvard Medical School, Boston, MA, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Vijaykumar T; Department of Medical Oncology, Jerome Lipper Multiple Myeloma Center, Dana Farber Cancer Institute, Boston, MA, USA.; Liu J; Department of Medical Oncology, Jerome Lipper Multiple Myeloma Center, Dana Farber Cancer Institute, Boston, MA, USA.; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.; Waldschmidt JM; Department of Medical Oncology, Jerome Lipper Multiple Myeloma Center, Dana Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Nair MS; Department of Medical Oncology, Jerome Lipper Multiple Myeloma Center, Dana Farber Cancer Institute, Boston, MA, USA.; Anand P; Department of Medical Oncology, Jerome Lipper Multiple Myeloma Center, Dana Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Dimitrova V; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Montanaro A; Harvard Medical School, Boston, MA, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; University of Parma, Department of Medicine and Surgery, Parma, Italy.; Yee AJ; Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital, Boston, MA, USA.; Munshi NC; Department of Medical Oncology, Jerome Lipper Multiple Myeloma Center, Dana Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Boston VA Healthcare System, Boston, MA, USA.; Anderson KC; Department of Medical Oncology, Jerome Lipper Multiple Myeloma Center, Dana Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Martin N; Bristol Myers Squibb, Seattle, WA, USA.; Kaiser SM; Bristol Myers Squibb, Seattle, WA, USA.; Raab MS; Heidelberg Myeloma Center, Department of Medicine V, University Hospital and Medical Faculty, Heidelberg University, Heidelberg, Germany.; Raje NS; Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital, Boston, MA, USA.; Knoechel B; Harvard Medical School, Boston, MA, USA. birgit.knoechel@hci.utah.edu.; Broad Institute of MIT and Harvard, Cambridge, MA, USA. birgit.knoechel@hci.utah.edu.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. birgit.knoechel@hci.utah.edu.; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA. birgit.knoechel@hci.utah.edu.; Lohr JG; Department of Medical Oncology, Jerome Lipper Multiple Myeloma Center, Dana Farber Cancer Institute, Boston, MA, USA. jens.lohr@hci.utah.edu.; Harvard Medical School, Boston, MA, USA. jens.lohr@hci.utah.edu.; Broad Institute of MIT and Harvard, Cambridge, MA, USA. jens.lohr@hci.utah.edu.; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA. jens.lohr@hci.utah.edu.

Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

Branagan, Andrew R. ; Lei, Matthew M ; Maron, Jenny S ; Yee, Andrew J ; O'Donnell, Elizabeth ; Castillo, Jorge J. ; Raje, Noopur S. ; Treon, Steven P ; Flynn, Catherine A ; Mo, Clifton C. ; Nadeem, Omar ; Richardson, Paul G. ; Panaroni, Cristina ; Meid, Kirsten ; Bernstein, Zachary S. ; Lyons, Rebecca T. ; Hunter, Zachary R ; Guerrera, Maria Luisa ; Gammon, Marilyn T. ; Lively, Kathleen J. ; Packer, Lisette ; Waterman, Matthew ; Gallagher, Raquel ; Juleg, Boris ; Alter, Galit ; Sarosiek, Shayna

In Blood 23 November 2021 138 Supplement 1:3801-3801

Nakamoto-Matsubara R; Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Nardi V; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Horick N; Biostatistics Center, Massachusetts General Hospital, Boston, MA, USA.; Fukushima T; Center for Regenerative Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Han RS; Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Shome R; Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Ochi K; Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Panaroni C; Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Fulzele K; Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Rexha F; Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Branagan AR; Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Cirstea D; Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Yee AJ; Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Scadden DT; Center for Regenerative Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Raje NS; Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA. nraje@mgh.harvard.edu.

Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

Dimopoulos MA; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.; Migkou M; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.; Bhutani M; Atrium Health, Levine Cancer Institute, Charlotte, NC, USA.; Ailawadhi S; Mayo Clinic, Jacksonville, FL, USA.; Kalff A; The Alfred Hospital, Melbourne, Australia.; Walcott FL; Early Oncology Research and Development, AstraZeneca, Gaithersburg, MD, USA.; Pore N; Early Oncology Research and Development, AstraZeneca, Gaithersburg, MD, USA.; Brown M; Early Oncology Research and Development, AstraZeneca, Gaithersburg, MD, USA.; Wang F; Early Oncology Research and Development, AstraZeneca, Gaithersburg, MD, USA.; Cheng LI; Clinical Pharmacology and Safety Sciences, BioPharmaceuticals Research and Development, AstraZeneca, Gaithersburg, MD, USA.; Kagiampakis I; Translational Medicine Bioinformatics, AstraZeneca, Gaithersburg, MD, USA.; Williams M; Translational Medicine, AstraZeneca, Gaithersburg, MD, USA.; Kinneer K; Translational Medicine, AstraZeneca, Gaithersburg, MD, USA.; Wu Y; Clinical Pharmacology and Safety Sciences, BioPharmaceuticals Research and Development, AstraZeneca, Gaithersburg, MD, USA.; Jiang Y; Clinical Pharmacology and Safety Sciences, BioPharmaceuticals Research and Development, AstraZeneca, Gaithersburg, MD, USA.; Kubiak RJ; Clinical Pharmacology and Safety Sciences, BioPharmaceuticals Research and Development, AstraZeneca, Gaithersburg, MD, USA.; Zonder JA; Karmanos Cancer Institute, Detroit, MI, USA.; Larsen J; Mayo Clinic, Scottsdale, AZ, USA.; Sirdesai S; The Alfred Hospital, Melbourne, Australia.; Yee AJ; Massachusetts General Hospital, Boston, MA, USA.; Kumar S; Mayo Clinic, Rochester, MN, USA.

Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE

Kanjee Z; Department of Medicine, Beth Israel Deaconess Medical Center, Boston.; Department of Medicine, Harvard Medical School, Boston.; Czawlytko CL; Department of Radiology, Massachusetts General Hospital, Boston.; Department of Radiology, Harvard Medical School, Boston.; Cheung PW; Department of Medicine, Harvard Medical School, Boston.; Department of Medicine, Massachusetts General Hospital, Boston.; Yee AJ; Department of Medicine, Harvard Medical School, Boston.; Department of Medicine, Massachusetts General Hospital, Boston.; Ray LJ; Department of Pathology, Massachusetts General Hospital, Boston.; Department of Pathology, Harvard Medical School, Boston.

Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE; In Process

Gal ZT; Harvard Medical School, 25 Shattuck St, Boston, MA, USA 02115; Department of Neurosurgery, Mass General Brigham, 15 Parkman St, WAC 745, Boston, MA, USA 02114.; Wetzel EA; Harvard Medical School, 25 Shattuck St, Boston, MA, USA 02115; Department of Neurosurgery, Mass General Brigham, 15 Parkman St, WAC 745, Boston, MA, USA 02114.; Nahed BV; Harvard Medical School, 25 Shattuck St, Boston, MA, USA 02115; Department of Neurosurgery, Mass General Brigham, 15 Parkman St, WAC 745, Boston, MA, USA 02114.; Saylor PJ; Harvard Medical School, 25 Shattuck St, Boston, MA, USA 02115; Mass General Cancer Center, Mass General Brigham, 55 Fruit St, Boston, MA, USA 02114.; Hirsch JA; Harvard Medical School, 25 Shattuck St, Boston, MA, USA 02115; Department of Radiology, Mass General Brigham, 55 Fruit St, Boston, MA, USA 02114.; Marciscano AE; Harvard Medical School, 25 Shattuck St, Boston, MA, USA 02115; Department of Radiation Oncology, Mass General Brigham, 55 Fruit St, Boston, MA, USA 02114.; Raje NS; Harvard Medical School, 25 Shattuck St, Boston, MA, USA 02115; Mass General Cancer Center, Mass General Brigham, 55 Fruit St, Boston, MA, USA 02114.; Tobert DG; Harvard Medical School, 25 Shattuck St, Boston, MA, USA 02115; Department of Orthopaedic Surgery, Mass General Brigham, 55 Fruit St, Boston, MA, USA 02114.; Yee AJ; Harvard Medical School, 25 Shattuck St, Boston, MA, USA 02115; Mass General Cancer Center, Mass General Brigham, 55 Fruit St, Boston, MA, USA 02114.; Shankar GM; Harvard Medical School, 25 Shattuck St, Boston, MA, USA 02115; Department of Neurosurgery, Mass General Brigham, 15 Parkman St, WAC 745, Boston, MA, USA 02114. Electronic address: gshankar@mgh.harvard.edu.

Publisher: Elsevier Science Inc Country of Publication: United States NLM ID: 101130732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-1632 (Electronic) Linking ISSN: 15299430 NLM ISO Abbreviation: Spine J Subsets: MEDLINE

Branagan AR; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA.; Mo C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Lei M; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA.; Gustine JN; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA.; Yee AJ; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA.; O'Donnell E; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA.; Castillo JJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Nadeem O; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Flynn C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Bernstein Z; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA.; Nakamoto-Matsubara R; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA.; Meid K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Verma R; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA.; Hunter ZR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Guerrera ML; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Alter G; Division of Medical Sciences, Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA.; Burke J; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA.; Harrington C; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA.; Agyemang E; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA.; Gammon M; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA.; Lively K; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA.; Packer L; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA.; Horick N; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA.; Laubach J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Mitsiades CS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Munshi N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Anderson KC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Treon SP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Richardson PG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Raje NS; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA.; Sarosiek SR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.

Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Hassoun, Hani, MD; Jacobus, Susanna J; Richardson, Paul G., MD; Zonder, Jeffrey, MD; Voorhees, Peter M., MD; Kaufman, Jonathan L., MD; Yee, Andrew J, MD; Scott, Emma C, MD; Torka, Pallawi, MD; Libby, Edward N., MD; Reeves, Brandi; Wang, Michael L., MD; Anderson, Larry D., Jr., MD, PhD; Milner, Carter; Gasparetto, Cristina, MD; Agha, Mounzer; Khan, Dr. Abdullah, MBBS; Hurd, David D; Avigan, David E., MD; Costello, Caitlin; Jakubowiak, Andrzej, MD, PhD; Lonial, Sagar, MD, FACP; Raje, Noopur S, MD; Medvedova, Eva, MD; McCarthy, Dr. Philip L., MD; Orlowski, Robert Z., MD, PhD; Nadeem, Omar, MD; Laubach, Jacob, MD; Pasquini, Marcelo, MD; Giralt, Sergio, MD. FACP, FASTCT; Masone, Kelly; Samur, Mehmet; Perrot, Aurore, MD; Moreau, Philippe; Avet-Loiseau, Hervé, MD, PhD; Weller, Edie, PhD; Munshi, Nikhil C., MD; Anderson, Kenneth C., MD

Transplantation and Cellular Therapy. 29(2):S396-S397

Liu Y; Department of Medical Oncology, Dana-Farber Cancer Institute, Jerome Lipper Center for Multiple Myeloma Research, Harvard Medical School, Boston, MA, USA.; Mo CC; Department of Medical Oncology, Dana-Farber Cancer Institute, Jerome Lipper Center for Multiple Myeloma Research, Harvard Medical School, Boston, MA, USA.; Hartley-Brown MA; Department of Medical Oncology, Dana-Farber Cancer Institute, Jerome Lipper Center for Multiple Myeloma Research, Harvard Medical School, Boston, MA, USA.; Division of Hematology, Brigham and Women's Hospital, Boston, MA, USA.; Sperling AS; Department of Medical Oncology, Dana-Farber Cancer Institute, Jerome Lipper Center for Multiple Myeloma Research, Harvard Medical School, Boston, MA, USA.; Division of Hematology, Brigham and Women's Hospital, Boston, MA, USA.; Midha S; Department of Medical Oncology, Dana-Farber Cancer Institute, Jerome Lipper Center for Multiple Myeloma Research, Harvard Medical School, Boston, MA, USA.; Division of Hematology, Brigham and Women's Hospital, Boston, MA, USA.; Yee AJ; Massachusetts General Cancer Center, Harvard Medical School, Boston, MA, USA.; Bianchi G; Department of Medical Oncology, Dana-Farber Cancer Institute, Jerome Lipper Center for Multiple Myeloma Research, Harvard Medical School, Boston, MA, USA.; Division of Hematology, Brigham and Women's Hospital, Boston, MA, USA.; Piper C; Department of Medical Oncology, Dana-Farber Cancer Institute, Jerome Lipper Center for Multiple Myeloma Research, Harvard Medical School, Boston, MA, USA.; Tattersall A; Department of Medical Oncology, Dana-Farber Cancer Institute, Jerome Lipper Center for Multiple Myeloma Research, Harvard Medical School, Boston, MA, USA.; Nadeem O; Department of Medical Oncology, Dana-Farber Cancer Institute, Jerome Lipper Center for Multiple Myeloma Research, Harvard Medical School, Boston, MA, USA.; Laubach JP; Department of Medical Oncology, Dana-Farber Cancer Institute, Jerome Lipper Center for Multiple Myeloma Research, Harvard Medical School, Boston, MA, USA.; Richardson PG; Department of Medical Oncology, Dana-Farber Cancer Institute, Jerome Lipper Center for Multiple Myeloma Research, Harvard Medical School, Boston, MA, USA.

Publisher: Taylor & Francis Country of Publication: England NLM ID: 101485942 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1747-4094 (Electronic) Linking ISSN: 17474094 NLM ISO Abbreviation: Expert Rev Hematol Subsets: MEDLINE